RCVi
/ BravoVax
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 25, 2023
Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine
(clinicaltrials.gov)
- P1 | N=60 | Not yet recruiting | Sponsor: Wuhan BravoVax Co., Ltd. | Trial completion date: Mar 2024 ➔ Jul 2024 | Initiation date: Mar 2023 ➔ Jun 2023 | Trial primary completion date: Sep 2023 ➔ Dec 2023
Trial completion date • Trial initiation date • Trial primary completion date • Infectious Disease • Novel Coronavirus Disease
1 to 1
Of
1
Go to page
1